Cervical Cancer

For over 50 years, routine use of the Pap test to screen for cervical cancer has reduced deaths from the disease by more than 70%.  It is hoped with wide-spread vaccination and improved screening strategies, fewer and fewer women will be affected by cervical cancer and pre-cancers in the future.

The Foundation for Women’s Cancer has divided information about cervical cancer into two sections, the first with information about screening and prevention, and the second for women who have experienced a diagnosis of cervical cancer or pre-cancer.

We always are eager to hear your opinions and try to answer your questions, though we cannot provide specific medical advice. Please contact us at info@foundationforwomenscancer.org.

The Foundation for Women’s Cancer offers educational materials that explore this in more depth.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.